Skip to main content
GRAL
NASDAQ Industrial Applications And Services

GRAIL CEO Joshua Ofman Files to Sell 71,452 Shares Worth $5.77M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$107.97
Mkt Cap
$4.823B
52W Low
$39.295
52W High
$118.84
52W Position info
175% above low
Off High info
9.1% below high
Rel. Volume info
4.6× avg
Market data snapshot near publication time

GRAL has more than doubled off its 52-week low of $39.295 on elevated volume (4.6× avg).

Summary

GRAIL CEO Joshua Ofman filed to sell 71,452 shares worth approximately $5.77 million under a pre-existing 10b5-1 plan, a material increase from his prior 10,000-share notice.


Key Events · Ownership and Investor Activity · GRAL

  • CEO Files to Sell 71,452 Shares

    Joshua Ofman filed a Form 144 to sell 71,452 shares worth approximately $5.77 million, a material increase from his prior 10,000-share notice in August.

  • Sale Under Pre-Existing 10b5-1 Plan

    The sale is executed under a 10b5-1 plan adopted December 2, 2025, indicating the transaction was pre-planned rather than a reaction to current events.

  • Shares Sourced from Options and RSUs

    The filing discloses 26,452 shares acquired via option exercise on September 21, 2026, and 45,000 shares from RSUs acquired August 18, 2024.

  • Prior Sale History

    Ofman previously sold 5,000 shares for approximately $425,098 on August 27, 2026, under the same 10b5-1 plan.


Analysis · GRAL · Industrial Applications And Services

A significant insider distribution is unfolding at GRAIL: CEO Joshua Ofman has filed a Form 144 to sell 71,452 shares worth approximately $5.77 million, a sharp increase from the 10,000 shares he noticed in August. The sale is executed under a pre-existing 10b5-1 plan adopted in December 2025, but the size — roughly 0.16% of shares outstanding — makes it a notable event. Adding to the scrutiny, the filing comes just two days before the FDA advisory committee meeting on Galleri.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 29.6% of the 1645 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GRAL was trading at $107.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $39.30 to $118.84. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRAL - Latest Insights

GRAL
Sep 23, 2026, 6:17 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $108.52
Real-time Price: $140.02 info
Change: +$31.50 (+29%) info
Market Cap: $6.254B info
GRAL
Sep 23, 2026, 8:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $109.91
Real-time Price: $140.02 info
Change: +$30.11 (+27%) info
Market Cap: $6.254B info
GRAL
Sep 21, 2026, 12:37 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $107.76
Real-time Price: $140.02 info
Change: +$32.26 (+30%) info
Market Cap: $6.254B info
GRAL
Aug 06, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $64.97
Real-time Price: $140.02 info
Change: +$75.05 (+116%) info
Market Cap: $6.254B info
GRAL
Aug 05, 2026, 4:02 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $68.00
Real-time Price: $140.02 info
Change: +$72.02 (+106%) info
Market Cap: $6.254B info